Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valbenazine for the Treatment of Trichotillomania in Adults
NCT05207085Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Feb 2024
- Primary completion
- Feb 2027
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valbenazine in trichotillomania (TTM), sponsored by Yale University. Started Feb 2024; status: recruiting.
02
Drugs
valbenazine
03
Conditions
trichotillomania (TTM)
Beyond the preview
Go deeper on NCT05207085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05207085.